191 related articles for article (PubMed ID: 38077321)
1. Expansion of CD4+ cytotoxic T lymphocytes with specific gene expression patterns may contribute to suppression of tumor immunity in oral squamous cell carcinoma: single-cell analysis and
Chen H; Sameshima J; Yokomizo S; Sueyoshi T; Nagano H; Miyahara Y; Sakamoto T; Fujii S; Kiyoshima T; Guy T; Nakamura S; Moriyama M; Kaneko N; Kawano S
Front Immunol; 2023; 14():1305783. PubMed ID: 38077321
[TBL] [Abstract][Full Text] [Related]
2. CD4
Perugino CA; Kaneko N; Maehara T; Mattoo H; Kers J; Allard-Chamard H; Mahajan VS; Liu H; Della-Torre E; Murphy SJH; Ghebremichael M; Wallace ZS; Bolster MB; Harvey LM; Mylvaganam G; Tuncay Y; Liang L; Montesi SB; Zhang X; Tinju A; Mochizuki K; Munemura R; Sakamoto M; Moriyama M; Nakamura S; Yosef N; Stone JH; Pillai S
J Allergy Clin Immunol; 2021 Jan; 147(1):368-382. PubMed ID: 32485263
[TBL] [Abstract][Full Text] [Related]
3. Improving function of cytotoxic T-lymphocytes by transforming growth factor-β inhibitor in oral squamous cell carcinoma.
Kondo Y; Suzuki S; Takahara T; Ono S; Goto M; Miyabe S; Sugita Y; Ogawa T; Ito H; Satou A; Tsuzuki T; Yoshikawa K; Ueda R; Nagao T
Cancer Sci; 2021 Oct; 112(10):4037-4049. PubMed ID: 34309966
[TBL] [Abstract][Full Text] [Related]
4. Single-cell transcriptomics reveal the intratumoral landscape of infiltrated T-cell subpopulations in oral squamous cell carcinoma.
Chen J; Yang J; Li H; Yang Z; Zhang X; Li X; Wang J; Zhang Y; Chen S; Song M
Mol Oncol; 2021 Apr; 15(4):866-886. PubMed ID: 33513276
[TBL] [Abstract][Full Text] [Related]
5. Granzyme K- and amphiregulin-expressing cytotoxic T cells and activated extrafollicular B cells are potential drivers of IgG4-related disease.
Koga R; Maehara T; Aoyagi R; Munemura R; Murakami Y; Doi A; Kono M; Yamamoto H; Niiro H; Kiyoshima T; Tanabe M; Nakano T; Matsukuma Y; Kawano M; Stone JH; Pillai S; Nakamura S; Kawano S
J Allergy Clin Immunol; 2024 Apr; 153(4):1095-1112. PubMed ID: 38092138
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of tumor-infiltrating immune cells in clinical early-stage oral squamous cell carcinoma.
Huang Z; Lu Y; Wang W; Xie N; Yi C; Xiong G; Xu X; Zhang M; Wang C
J Oral Pathol Med; 2023 May; 52(5):372-380. PubMed ID: 36135715
[TBL] [Abstract][Full Text] [Related]
8. CD4
Piersiala K; Farrajota Neves da Silva P; Hjalmarsson E; Kolev A; Kågedal Å; Starkhammar M; Elliot A; Marklund L; Margolin G; Munck-Wikland E; Kumlien Georén S; Cardell LO
Cancer Sci; 2021 Mar; 112(3):1048-1059. PubMed ID: 33462898
[TBL] [Abstract][Full Text] [Related]
9. Distinct expression patterns of Toll-like receptor 7 in tumour cells and fibroblast-like cells in oral squamous cell carcinoma.
Ni YH; Ding L; Zhang DY; Hou YY; Huang X; Hu Q
Histopathology; 2015 Nov; 67(5):730-9. PubMed ID: 25828894
[TBL] [Abstract][Full Text] [Related]
10. Functional and T cell receptor gene usage analysis of cytotoxic T lymphocytes in fresh tumor-infiltrating lymphocytes from human head and neck cancer.
Chikamatsu K; Eura M; Nakano K; Masuyama K; Ishikawa T
Jpn J Cancer Res; 1995 May; 86(5):477-83. PubMed ID: 7790320
[TBL] [Abstract][Full Text] [Related]
11. T-cell receptor Vbeta gene usage by T cells reactive with the tumor-rejection antigen SART-1 in oral squamous cell carcinoma.
Kumamaru W; Nakamura S; Kadena T; Yamada A; Kawamura E; Sasaki M; Ohyama Y; Toyoshima T; Hayashida JN; Itoh K; Shirasuna K
Int J Cancer; 2004 Feb; 108(5):686-95. PubMed ID: 14696095
[TBL] [Abstract][Full Text] [Related]
12. Trametinib improves Treg selectivity of anti-CCR4 antibody by regulating CCR4 expression in CTLs in oral squamous cell carcinoma.
Ono S; Suzuki S; Kondo Y; Okubo I; Goto M; Ogawa T; Kato H; Ito H; Takahara T; Satou A; Tsuzuki T; Yoshikawa K; Nagao T; Ueda R
Sci Rep; 2022 Dec; 12(1):21678. PubMed ID: 36522365
[TBL] [Abstract][Full Text] [Related]
13. Terminally differentiated cytotoxic CD4
Ma X; Zuo Y; Hu X; Chen S; Zhong K; Xue R; Gui S; Liu K; Li S; Zhu X; Yang J; Deng Z; Liu X; Xu Y; Liu S; Shi Z; Zhou M; Tang Y
CNS Neurosci Ther; 2024 Mar; 30(3):e14682. PubMed ID: 38499993
[TBL] [Abstract][Full Text] [Related]
14. CD8
Farhood B; Najafi M; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
[TBL] [Abstract][Full Text] [Related]
15.
Shi Y; Ren X; Cao S; Chen X; Yuan B; Brasil da Costa FH; Rodriguez Rosario AE; Corona A; Michikawa C; Veeramachaneni R; Osman AA; Xie T; Wang W; Sikora AG; Myers JN; Rangel R
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37604640
[TBL] [Abstract][Full Text] [Related]
16. Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts.
Woolaver RA; Wang X; Krinsky AL; Waschke BC; Chen SMY; Popolizio V; Nicklawsky AG; Gao D; Chen Z; Jimeno A; Wang XJ; Wang JH
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33414263
[TBL] [Abstract][Full Text] [Related]
17. Identification of a Favorable Prognostic Subgroup in Oral Squamous Cell Carcinoma: Characterization of ITGB4/PD-L1
Ma SR; Liu JF; Jia R; Deng WW; Jia J
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371594
[TBL] [Abstract][Full Text] [Related]
18. Prognostic markers in oropharyngeal squamous cell carcinoma: focus on CD70 and tumour infiltrating lymphocytes.
De Meulenaere A; Vermassen T; Aspeslagh S; Zwaenepoel K; Deron P; Duprez F; Rottey S; Ferdinande L
Pathology; 2017 Jun; 49(4):397-404. PubMed ID: 28427753
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
20. TDO2+ myofibroblasts mediate immune suppression in malignant transformation of squamous cell carcinoma.
Hu S; Lu H; Xie W; Wang D; Shan Z; Xing X; Wang XM; Fang J; Dong W; Dai W; Guo J; Zhang Y; Wen S; Guo XY; Chen Q; Bai F; Wang Z
J Clin Invest; 2022 Oct; 132(19):. PubMed ID: 35972800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
